The franchisor setting the standard for excellence in printing and marketing solutions DENVER, Jan. 30, 2024 /PRNewswire/ — AlphaGraphics, a leading franchisor of printing and marketing solutions, has secured a spot on the prestigious Franchise 500® list of top franchisors in the nation for the fifth consecutive year. Entrepreneur’s Franchise 500® is the world’s first,… Continue reading AlphaGraphics celebrates fifth consecutive year on Entrepreneur’s Franchise 500® list
Category: Newswire
Now Available: Veeva Compass Suite of Commercial Data Products
Complete suite of modern patient, prescriber, and national data products for today’s complex therapies Compass Prescriber includes HCP-level projections for more than 4,000 brands and their prescriptions and procedures PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced the availability of the full Veeva Compass Suite of commercial data products for a more… Continue reading Now Available: Veeva Compass Suite of Commercial Data Products
Superior HealthPlan Celebrates 25 Years of Putting Members First
With more than 2 million members, Superior has grown into the largest Medicaid managed care organization in Texas. AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ — Superior HealthPlan (“Superior”), the leading managed care organization in the state of Texas and a wholly owned subsidiary of Centene Corporation (NYSE: CNC), is celebrating an important milestone – 25 years of delivering high-quality, local… Continue reading Superior HealthPlan Celebrates 25 Years of Putting Members First
Shutterstock Increases Quarterly Dividend By 11% to $0.30
New York, Jan. 30, 2024 /PRNewswire/ — Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform connecting brands and businesses to high-quality content, today announced that its Board of Directors has declared a cash dividend of $0.30 per share of outstanding common stock on January 29, 2024, payable on March 14, 2024, to stockholders of record… Continue reading Shutterstock Increases Quarterly Dividend By 11% to $0.30
Mrs. Butterworth’s® and Dunkin’® Partner to Introduce New Glazed Donut Flavored Syrup
New Dunkin’ Syrup Makes Breakfast Even Sweeter CHICAGO, Jan. 30, 2024 /PRNewswire/ — Mrs. Butterworth’s®, a brand of Conagra Brands, Inc. (NYSE: CAG), has teamed up with Dunkin’® to launch the new Mrs. Butterworth’s Dunkin’ Glazed Donut Flavored Pancake Syrup. The thick, rich pancake syrup with the irresistibly sweet flavor of a glazed donut will help… Continue reading Mrs. Butterworth’s® and Dunkin’® Partner to Introduce New Glazed Donut Flavored Syrup
ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
GARCHING / MUNICH, Germany and VANCOUVER, BC, Jan. 30, 2024 /PRNewswire/ — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical stage biotechnology company developing differentiated and highly targeted radiopharmaceuticals, today announced the signature of a global master clinical supply agreement to support the development of Alpha-9’s… Continue reading ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
Sensorium Therapeutics Expands Board Leadership with Addition of Simba Gill, Ph.D., as Independent Director
Gill brings decades of leadership experience building biotech companies, transformative platforms and developing products The company announces first Development Candidate Nomination, SENS-01, developed as a rapid-acting, well-tolerated therapeutic for anxiety, with immediate plans to start IND enabling studies and enter the clinic by 2025 BOSTON, Jan. 30, 2024 /PRNewswire/ — Sensorium Therapeutics (Sensorium), a biotechnology… Continue reading Sensorium Therapeutics Expands Board Leadership with Addition of Simba Gill, Ph.D., as Independent Director
Krensavage Asset Management Remains Opposed to Sun’s Predatory Bid for Taro
NEW YORK, Jan. 30, 2024 /PRNewswire/ — Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.’s bid for Taro Pharmaceutical Industries Ltd. Krensavage Asset Management LLC 610 Fifth Avenue Suite 301 New York, NY 10020 [email protected] Taro Special Committee Linda Benshoshan [email protected] Dear Linda, As the largest… Continue reading Krensavage Asset Management Remains Opposed to Sun’s Predatory Bid for Taro
Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands
Led by FTV Capital, with participation from NVIDIA and existing investors, funding will further solidify Kore.ai’s leading position in explosive advanced AI market ORLANDO, Fla., Jan. 30, 2024 /PRNewswire/ — Kore.ai, a leader in enterprise conversational and generative AI platform technology, today announced $150 million in funding. The strategic growth investment was led by FTV… Continue reading Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics
SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed to advance genetics-based drug discovery for rare diseases. The goal of the collaboration is to generate new insights focused on… Continue reading Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics